Genomics & Genetics Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genomics & Genetics Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Avian Influenza
Intervet develops prototype for mass application bird flu vaccine
July 14th, 2006
Akzo Nobel's animal health business, Intervet, made a breakthrough that, according to the company, could mean mass application of a dual vaccine against avian influenza and Newcastle Disease could be available in the near future. Together with scientists at the Friedrich-Loeffler-Institute (FLI) in Germany, Intervet has developed a prototype for a new generation vaccine offering protection against both infections which can be mass applied by spraying instead of injecting. The new prototype vaccine consists of a safe live vaccine against Newcastle Disease (a condition affecting many bird species), which acts as a carrier for the hemagglutinin gene -...
Source: Genomics & Genetics Weekly (2006-07-14)
|
